Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001017491-14-000030
Filing Date
2014-02-10
Accepted
2014-02-10 16:10:28
Documents
1
Period of Report
2014-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_139206661764118.html 4  
1 FORM 4 wf-form4_139206661764118.xml 4 3845
  Complete submission text file 0001017491-14-000030.txt   5336
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXMED, INC. 350 CORPORATE BLVD ROBBINSVILLE NJ 08691
Business Address
Oppenheim Leonard A (Reporting) CIK: 0001307647 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 14588684